Published in Medical Imaging Week, December 8th, 2007
"Chest radiographs and computed tomography (CT) findings, along with clinical course, were evaluated Patients complained of subacute dyspnea and hypoxia. Three patients improved after discontinuation of gefitinib, while remaining two showed no response," wrote H.S. Park and colleagues, Seoul National University, Medical Department.
The researchers concluded: "Unilateral or bilateral...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Week